Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.012 | 1 |